Naveris

Waltham, MA · Founded 2017 · Privately Held (backing)

Developer of a blood test technology designed to detect specific cancer subtypes and improve patient outcomes. Naveris is based in Waltham, MA and was founded in 2017. Its last known valuation is $81.5 million. It has raised $85.5 million across 3 recorded rounds; the latest was a $17.5 million early-stage round in Jun 2024.

Last price · $/share
—
Implied valuation
$81.5M
Total raised
$85.5M
Last round
Early Stage VC
Jun 2024
Cap table — not yet on record

Naveris's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Naveris with a free account
  • ·Watch Naveris: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Naveris

Where does Naveris's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Naveris's 3 recorded funding rounds.